Target intelligence / Profile preview

Host-microbiome interaction modulation

Molecular classification
Other
01

Overview

Host-microbiome interaction modulation refers to the purposeful or incidental alteration of the dynamic crosstalk between a host and its associated microbiome using dietary, pharmaceutical, microbial, or genetic interventions. Such modulation aims to restore or optimize homeostasis, influence disease outcomes, or investigate specific biological mechanisms. The modulation can impact immune responses, metabolism, barrier function, and neurological processes, and is being explored as a therapeutic strategy for a wide spectrum of diseases including inflammatory, metabolic, neurological, and infectious conditions. However, it is not a classical drug target such as a protein or receptor, but a holistic network involving multiple genes, signaling molecules, cells, and environmental factors.

Other names
host-microbiota interaction modulationhost-microbiome crosstalkmicrobiome modulationmicrobiota-host interaction
02

Mechanism of action

Mechanism of action includes modulation of immune response via microbial metabolites; shaping host signaling pathways/metabolite production; alteration of gut barrier integrity and function; suppression or activation of inflammation through immune signaling; crosstalk with the central nervous system (brain-gut axis); and restoration or disruption of microbial community structure.

03

Biological functions

Immune responseCell signalingMetabolism regulationBarrier function maintenanceBehavioral modulationOther
04

Disease associations

Inflammation (including chronic inflammatory diseases, e.g., IBD)Neurodegenerative diseaseInfectionCardiovascular diseaseMetabolic disorders (obesity, diabetes)Cancer (some evidence)Other
05

Safety considerations

Unpredictable microbiome shifts leading to dysbiosisUnintended immune activation or suppressionInfection risk (e.g., from fecal transplantation)Off-target effects (especially with engineered microbes)Variable response due to individual microbiome differences
06

Interacting drugs

Probiotics (live beneficial bacteria)

6 more in the full profile.

07

Biomarkers

Microbiome composition profiling (sequencing)Microbial metabolite levels (e.g., short-chain fatty acids, indole compounds)Host inflammatory markers (e.g., cytokines)Immune cell phenotypesBarrier integrity markers (e.g., tight junction proteins)Null (no specific single biomarker, panel-based approaches more common)

Beyond the preview

Go deeper on Host-microbiome interaction modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host-microbiome interaction modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call